Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 77 | SFEBES2021 | Next issue

Society for Endocrinology BES 2021

Edinburgh, United Kingdom
08 Nov 2021 - 10 Nov 2021

Card image cap
Join us in Edinburgh for the flagship event of the Society for Endocrinology

Early Careers and Plenary Orals

Early Career Prize Lecture Basic Science (1)

ea0077ec1.2 | Early Career Prize Lecture Basic Science (1) | SFEBES2021

Cardiometabolic disease burden and urine steroid metabolome in benign adrenocortical tumours: a case-control study

Prete Alessandro , Subramanian Anuradhaa , Bancos Irina , Chortis Vasileios , Tsagarakis Stylianos , Lang Katharina , Macech Magdalena , Delivanis Danae A , Pupovac Ivana D , Reimondo Giuseppe , Marina Ljiljana V , Deutschbein Timo , Balomenaki Maria , O’Reilly Michael W , Bednarczuk Tomasz , Zhang Catherine , Dusek Tina , Diamantopoulos Aristidis , Asia Miriam , Kondracka Agnieszka , Li Dingfeng , Masjkur Jimmy R , Quinkler Marcus , Ueland Grethe AE , Dennedy M Conall , Beuschlein Felix , Tabarin Antoine , Fassnacht Martin , Ivovic Miomira , Terzolo Massimo , Kastelan Darko , Young Jr William F , Manolopoulos Konstantinos N , Ambroziak Urszula , Vassiliadi Dimitra A , Taylor Angela E , Sitch Alice J , Nirantharakumar Krishnarajah , Arlt Wiebke

Background: The overwhelming majority of incidentally discovered adrenal tumours are benign adrenocortical adenomas. These can be non-functioning (NFAT) or associated with cortisol excess on a spectrum ranging from rare clinically overt adrenal Cushing’s syndrome (CS) to much more prevalent mild autonomous cortisol secretion (MACS) without signs of CS. The 1mg-overnight dexamethasone suppression test (DST) further differentiates MACS-1 (possible MACS; post-DST cortisol 50...